Mavens Biotech Key Ratios
BSE: 590083
₹0.47
₹-0.02
(-4.08%)
As on 07-Mar-2017IST
Market cap
₹5 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -40.58 | -8.89 | -8.46 | -71.83 | -53.47 |
| EBIT | 0.00 | -82.35 | -70.87 | -50.50 | -43.68 |
| Net Profit | 0.00 | -82.35 | -70.87 | -54.74 | -46.02 |
| EPS | 0.00 | -82.61 | -71.55 | -198.16 | -46.23 |
| Book Value | -- | -- | -7.61 | -2.25 | -2.31 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| 121.53 | 121.53 | -705.92 | 42.72 | 1,027.78 |
| Return on equity
| -2.28 | -2.34 | -7.93 | 0.75 | 0.34 |
| Return on Capital
| -0.31 | -1.16 | -2.04 | 0.75 | 0.34 |
| Return on Assets
| -2.03 | -2.14 | -7.11 | 0.71 | 0.32 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.00 |
Profitability
ROCE
-2.04
Lower than Peers by 15.28
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-2.04
|
0.75
|
0.34
|
-2.59
|
-2.29
|
|
Peer Median
|
13.24
|
16.44
|
17.47
|
11.52
|
--
|
ROE
-7.93
Lower than Peers by 13.82
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-7.93
|
0.75
|
0.34
|
-2.59
|
-2.29
|
|
Peer Median
|
5.89
|
17.13
|
19.66
|
11.55
|
--
|
ROA
-7.11
Lower than Peers by 10.65
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-7.11
|
0.71
|
0.32
|
-2.45
|
-2.17
|
|
Peer Median
|
3.55
|
8.03
|
7.73
|
3.48
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.01
|
3.78
|
7.01
|
7.65
|
--
|
Net Margin
-705.92
Lower than Peers by 709.50
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-705.92
|
42.72
|
1,027.78
|
-1,233.91
|
-559.13
|
|
Peer Median
|
3.58
|
4.20
|
5.41
|
3.75
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
9.19
|
-20.84
|
55.49
|
14.59
|
--
|
EBIT Growth
-1.96
Lower than Peers by 26.40
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-1.96
|
4.84
|
-11.73
|
-1.19
|
62.39
|
|
Peer Median
|
24.43
|
-30.12
|
27.10
|
95.62
|
--
|
Net Profit Growth
-1,115.09
Lower than Peers by 1,142.06
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-1,115.09
|
122.16
|
113.04
|
-10.34
|
84.61
|
|
Peer Median
|
26.97
|
-56.02
|
60.14
|
103.21
|
--
|
EPS Growth
-1,127.03
Lower than Peers by 1,150.82
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-1,127.03
|
117.65
|
113.18
|
-10.26
|
84.61
|
|
Peer Median
|
23.79
|
-46.67
|
41.30
|
108.81
|
--
|
Book Value Growth
-7.62
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-7.62
|
0.76
|
0.34
|
-2.55
|
-2.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.52
|
0.47
|
0.47
|
0.33
|
--
|
Current Ratio
0.29
Lower than Peers by 1.04
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
0.29
|
0.58
|
0.67
|
0.98
|
1.12
|
|
Peer Median
|
1.33
|
1.17
|
1.34
|
1.36
|
--
|
Quick Ratio
0.29
Lower than Peers by 0.64
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
0.29
|
0.58
|
0.67
|
0.98
|
1.12
|
|
Peer Median
|
0.93
|
0.78
|
0.77
|
0.90
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.58
|
4.31
|
7.25
|
3.96
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10.04
|
9.15
|
23.20
|
16.65
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.33
|
1.47
|
1.57
|
1.04
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
23.28
|
50.27
|
12.04
|
10.71
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.80
|
2.08
|
1.67
|
1.47
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.55
|
0.54
|
0.39
|
0.52
|
--
|
EV/EBITDA
-102.01
Lower than Peers by 119.62
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
-102.01
|
-163.61
|
-64.76
|
-77.29
|
-85.98
|
|
Peer Median
|
17.61
|
10.15
|
9.07
|
10.74
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
Mavens Biotech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3,214
|
2,276
|
1,250
|
1,133
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
